Full article access for Neurosurgery subscribers at Neurosurgery-Online.com.
BACKGROUND: Stenting for symptomatic intracranial atherosclerotic disease (ICAD) is a therapeutic option in patients who fail medical therapy.
OBJECTIVE: To determine the peri-procedural complication rates and midterm restenosis rates in patients treated with balloon expandable stents (BES) compared to self expanding stents (SES).
METHODS: A retrospective review of consecutive patients treated with intracranial stents at 5 institutions was performed. Predictors of 30 day stroke and death as well as midterm restenosis rates were analyzed.
